⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8040532 | 0.84 | — | — | |
| SCHEMBL20886771 | 0.81 | — | — | |
| SCHEMBL14316150 | 0.81 | — | — | |
| SCHEMBL866815 | 0.81 | — | — | |
| SCHEMBL20886817 | 0.81 | — | — | |
| SCHEMBL21788205 | 0.81 | — | — | |
| SCHEMBL10289799 | 0.81 | — | — | |
| SCHEMBL20886772 | 0.81 | — | — | |
| SCHEMBL22617773 | 0.81 | — | — | |
| SCHEMBL18611304 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021133924-A1 | GALECTIN-3 INHIBITING C-GLYCOSIDE KETONES, ETHERS, AND ALCOHOLS | MAGNANI JOHN L (US) | 2021-07-01 | — | — | WO | disclosed |
| WO-2017102068-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2017-06-22 | — | — | WO | disclosed |
| US-20160130275-A1 | PYRAZOLO[1,5-A]PYRIMIDINES FOR ANTIVIRAL TREATMENT | GILEAD SCIENCES, INC. | 2016-05-12 | — | — | US | disclosed |
| US-9238039-B2 | Pyrazolo[1,5-A]pyrimidines for antiviral treatment | GILEAD SCIENCES, INC. (US) | 2016-01-19 | — | — | US | disclosed |
| US-8809330-B2 | Pyrazolo[1,5-A]pyrimidines for antiviral treatment | GILEAD SCIENCES, INC. (US) | 2014-08-19 | — | — | US | disclosed |
| US-20140154240-A1 | PYRAZOLO[1,5-A]PYRIMIDINES FOR ANTIVIRAL TREATMENT | GILEAD SCIENCES, INC. | 2014-06-05 | — | — | US | disclosed |